Form 4 for PLAB PHOTRONICS INC
Accepted 2021-12-10 00:00:00 ET · period of report 2021-12-08 · accession 0001567619-21-021899 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-10 | 2021-12-08 | PLAB | KIRLIN PETER S | CEO | S - Sale+OE | $16.59 | -61.2K | 399.6K | -13% | -$1.02M |
| DM | 2021-12-10 | 2021-12-08 | PLAB | KIRLIN PETER S | CEO | M - OptEx | $8.80 | +61.2K | 408.7K | +18% | +$538.8K |
| DM | 2021-12-10 | 2021-12-08 | PLAB | KIRLIN PETER S | CEO | M - OptEx | $0.00 | -61.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2021-12-08 | S | D | 33,386 | $16.27 | 404,088 | D | — | — | (F1) The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Dr. Kirlin. (F3) Net proceeds of sale to fund children's education. (F2) This transaction was executed in multiple trades. The price reported above reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected. |
| 2 | Common | COMMON STOCK | 2021-12-08 | S | D | 4,464 | $16.79 | 399,624 | D | — | — | (F1) The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Dr. Kirlin. (F3) Net proceeds of sale to fund children's education. (F2) This transaction was executed in multiple trades. The price reported above reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected. |
| 3 | Common | COMMON STOCK | 2021-12-08 | M | A | 2,141 | $8.60 | 401,765 | D | — | — | |
| 4 | Common | COMMON STOCK | 2021-12-08 | S | D | 1,689 | $16.86 | 400,076 | D | — | — | (F1) The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Dr. Kirlin. (F3) Net proceeds of sale to fund children's education. (F2) This transaction was executed in multiple trades. The price reported above reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected. |
| 5 | Common | COMMON STOCK | 2021-12-08 | S | D | 452 | $17.64 | 399,624 | D | — | — | (F1) The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Dr. Kirlin. (F3) Net proceeds of sale to fund children's education. (F2) This transaction was executed in multiple trades. The price reported above reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected. |
| 6 | Common | COMMON STOCK | 2021-12-08 | M | A | 37,850 | $8.84 | 437,474 | D | — | — | |
| 7 | Common | COMMON STOCK | 2021-12-08 | S | D | 6,232 | $16.80 | 402,501 | D | — | — | (F1) The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Dr. Kirlin. (F3) Net proceeds of sale to fund children's education. (F2) This transaction was executed in multiple trades. The price reported above reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected. |
| 8 | Common | COMMON STOCK | 2021-12-08 | S | D | 2,877 | $17.45 | 399,624 | D | — | — | (F1) The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Dr. Kirlin. (F3) Net proceeds of sale to fund children's education. (F2) This transaction was executed in multiple trades. The price reported above reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected. |
| 9 | Common | COMMON STOCK | 2021-12-08 | M | A | 12,150 | $8.84 | 411,774 | D | — | — | |
| 10 | Common | COMMON STOCK | 2021-12-08 | S | D | 5,596 | $16.68 | 406,178 | D | — | — | (F1) The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Dr. Kirlin. (F3) Net proceeds of sale to fund children's education. (F2) This transaction was executed in multiple trades. The price reported above reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected. |
| 11 | Common | COMMON STOCK | 2021-12-08 | S | D | 6,554 | $17.29 | 399,624 | D | — | — | (F1) The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Dr. Kirlin. (F3) Net proceeds of sale to fund children's education. (F2) This transaction was executed in multiple trades. The price reported above reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected. |
| 12 | Common | COMMON STOCK | 2021-12-08 | M | A | 9,109 | $8.60 | 408,733 | D | — | — | |
| 13 | Derivative | Stock Options (Right to Buy) | 2021-12-08 | M | D | 12,150 | $0.00 | 0 | D | $8.84 · 2019-05-04 to 2025-05-04 | 12,150 COMMON STOCK | |
| 14 | Derivative | Non-Qualified Stock Options | 2021-12-08 | M | D | 37,850 | $0.00 | 0 | D | $8.84 · 2019-05-04 to 2025-05-04 | 37,850 COMMON STOCK | |
| 15 | Derivative | Stock Options (Right to Buy) | 2021-12-08 | M | D | 2,141 | $0.00 | 3,750 | D | $8.60 · 2021-01-02 to 2028-01-02 | 2,141 COMMON STOCK | |
| 16 | Derivative | Non-Qualified Stock Options | 2021-12-08 | M | D | 9,109 | $0.00 | 0 | D | $8.60 · 2021-01-02 to 2028-01-02 | 9,109 COMMON STOCK |